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Preferential binding of oxidized LDL to rat glomeruli in vivo and
cultured mesangial cells in vitro. Hyperlipidemia may contribute to the
pathogenesis of glomerular sclerosis. We therefore compared binding
and uptake of native LDL and oxidized LDL (Ox-LDL) to cultured
mesangial cells (MC) and the resulting effects on prostaglandin gener-
ation and cell proliferation. Ox-LDL, prepared from native LDL by
incubation with copper, was bound to MC in a concentration dependent
manner with a four- to fivefold increase in binding over LDL. In
competition binding experiments Ox-LDL competed to 90% with LDL
for binding sites, but LDL only displaced Ox-LDL to 15%. Further-
more polyinosinic acid, which blocks binding of Ox-LDL to macro-
phages, inhibited binding of Ox-LDL but not that of LDL to MC.
Mesangial cells also preferentially took up Ox-LDL over LDL, and
Ox-LDL resulted in higher ['4C1 oleate incorporation into cholesteryl
esters than LDL, findings consistent with different handling of Ox-LDL
and LDL by MC. LDL slightly stimulated mesangial cell proliferation at
low concentration (10 to 50 g/ml of LDL) returning to control levels at
100 and 250 sg/ml. In contrast Ox-LDL inhibited cell proliferation in a
concentration-dependent manner, starting at concentrations as low as
10 to 25 g/ml of Ox-LDL. Direct observations of mesangial cells by
phase contrast microscopy confirmed the cytotoxic effects of Ox-LDL.
Addition of Ox-LDL to mesangial cells resulted in a concentration-
dependent increase in POE2 synthesis within one hour, while at this
time point LDL had no significant effect. To assess in vivo glomerular
uptake, we infused radioiodinated native LDL and Ox-LDL into the
suprarenal aorta of normal Sprague-Dawley rats and determined radio-
activity in isolated glomeruli. These studies showed that glomerular
uptake of Ox-LDL also markedly exceeded that of LDL, reaching
levels observed in the liver, a major site of LDL and Ox-LDL uptake.
In conclusion, MC have binding sites for both LDL and Ox-LDL.
Uptake of Ox-LDL stimulates PGE2 production and inhibits prolifera-
tion of mesangial cells, factors that may be of significance for lipid-
induced glomerular injury.
Hyperlipidemia is associated with a variety of renal diseases,
and experimental evidence suggests a role for hyperlipidemia in
the progression of glomerular diseases [1, 2]. Dietary choles-
terol supplementation has been shown to accelerate the devel-
opment of sclerotic glomerular lesions in experimental models
of renal disease and in normal animals, while cholesterol
lowering agents abrogate experimental glomerular injury [1—4].
Glomerular lesions of hyperlipidemia have been compared to
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atherosclerotic lesions and a similarity in their pathogenesis has
been proposed [1, 2]. The development of atherosclerotic
lesions has been linked to local accumulation of low density
lipoprotein (LDL) and to its local oxidation [5]. This is sup-
ported by reports showing that oxidative modification of LDL
can be catalyzed by endothelial and vascular smooth muscle
cells [6] and that atheromatous lesions contain oxidized LDL
(Ox-LDL) [7, 81. The oxidized form of LDL may then exert
deleterious effects on the vessel wall as Ox-LDL is cytotoxic to
endothelial and vascular smooth muscle cells [6, 9].
Some cell types such as monocytes and macrophages, he-
patic Kupifer cells and to some extent endothelial cells have
specific uptake mechanisms for modified LDL [10—16]. These
cells have a distinct receptor for modified LDL which is distinct
from the LDL receptor and has been named the scavenger
receptor. In contrast to LDL, uptake of Ox-LDL by macro-
phages is not regulated and considerably exceeds that of native
LDL [14, 16]. This results in intracellular lipid accumulation
and the formation of foam cells [5]. There is evidence that the
local formation of the cytotoxic Ox-LDL and its uptake by
scavenger receptors may contribute to the pathophysiology of
hyperlipidemic lesions [51. This could involve both direct cyto-
toxicity as well as formation and release of a number of
mediators. For example, the uptake of Ox-LDL by macro-
phages stimulates synthesis of eicosanoids [17], which may in
turn contribute to the general pathophysiology of hyperlipid-
emia [18]. We have recently reported that hyperlipidemia
induced by cholesterol feeding causes marked changes in renal
hemodynamics which appeared to be mediated, to a major
extent, by increased eicosanoid synthesis [19].
In the glomerulus the mesangial cell plays the role of a
specialized pericyte. This cell contributes to the regulation of
glomerular filtration, produces mesangial matrix components
and participates in a number of glomerular disease processes
[20, 21]. Mesangial cells are continuously exposed to plasma
components, including lipoproteins, as the mesangium is only
separated from the capillary lumen by a fenestrated endothe-
hum without intervening basement membrane. Mesangial
changes are prominent in animals with experimental hyperlip-
idemia [2]. Thus the mesangial cell, together with the glomeru-
lar epithehial cell [22] and possibly endothelial cells, may
contribute to the development of glomerular sclerotic lesions
that are seen in hyperlipidemia. We and others have previously
demonstrated receptor-mediated binding and uptake of LDL by
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mesangial cells [23, 241. The purpose of the present study is to
compare the binding and uptake of LDL and oxidized LDL and
the associated effects on cultured mesangial cells. Our studies
demonstrate that mesangial cells in culture avidly bind and take
up Ox-LDL to a greater extent than LDL. In accordance with
these in vitro studies, we also demonstrate a tenfold increase in
glomerular uptake of Ox-LDL compared to native LDL in vivo
after intra-aortic infusion in rats. Finally we show that Ox-LDL
is cytotoxic to cultured mesangial cells and causes a rapid
increase in PGE2 synthesis. Our data are consistent with the
hypothesis that Ox-LDL can contribute to glornerular injury in
a fashion similar to that in atherosclerotic lesions.
Methods
Materials
Carrier free [125J] sodium and [3H] thymidine were obtained
from Amersham (Arlington Heights, Illinois, USA). RPMI
1640, penicillin-streptomycin and fetal calf serum were obtained
from Flow Laboratories (Helsinki, Finland). Nu serum and
Duibecco's phosphate buffered saline were purchased from
Gibco Laboratories (Grand Island, New York, USA). Fatty
acid free bovine serum albumin, thiobarbituric acid, tetrame-
thoxypropene were obtained from Sigma Chemical Co. (St.
Louis, Missouri, USA). Polyinosinic acid was from Pharmacia
(Piscataway, New Jersey, USA) and enzymobeads were from
Biorad, (Richmond, California, USA). Autoradiography emul-
sion was purchased from Kodak Laboratories, (Rochester,
New York, USA).
Albumin bound ['4C] oleate was prepared by the method of
Van Harken, Dixon and Heimberg [25]. ['4C] Oleic acid was
obtained from New England Nuclear (58 mCilm mol, Boston,
Massachusetts, USA) and evaporated to dryness and dissolved
in 10 ml of 0.9% NaCI (pH 7.4) containing 0.1 glml of BSA.
Aliquots were stored at 0°C until use in experiments.
Cell culture
Mesangial cells were isolated from male Sprague-Dawley rats
(Charles River Breeders, Wilmington, Massachusetts, USA)
which weighed 150 grams and were maintained on tap water and
Purina Rat Chow ad libitum. Kidneys were removed under
pentobarbital anesthesia. The glomeruli were isolated and cul-
tured as previously described [261. Culture medium consisted of
RPM! 1640 supplemented by 10% fetal calf serum with added
penicillin and streptomycin. Once confluent (15 to 20 days after
glomerular isolation), the mesangial cells were then subcultured
at two to three week intervals.
Preparation and labeling of lipoproteins
Lipoproteins were prepared from normolipidemic fasting
volunteers. After the addition of 0.02% EDTA and 0.05%
Na-azide to the plasma, LDL (d 1.019 to 1.063 g/ml) was
prepared by sequential ultracentrifugation at 15°C [171. Solid
KBr was used for density adjustment. The lipoprotein was
recentrifuged at d 1.063 g/ml and dialyzed for 24 hours at 4°C
against 150 mM NaC1, 1 mi NaHCO3, pH 7.5 containing 0.01%
azide and 0.02% EDTA. Prior to use EDTA and azidize were
removed by a short (2 hr) dialysis at 4°C. To oxidize LDL,
EDTA was removed by dialysis and the LDL was incubated
under oxygen for 16 hours at 30°C after the addition of 10 jiM
Cu Protein concentrations were determined by the Bradford
method. LDL was radiolabeled with 125! using the Enzymobead
method (Biorad, Richmond, California, USA), which utilized a
lactoperoxidase and glucose oxidase. 125j LDL was separated
from unincorporated 125j by Sephadex gel filtration. '251-LDL
was then oxidized by the above method. The labeled lipopro-
teins were dialyzed for 24 hours at 4°C. Specific activities
ranged from 1 to 5 x 106 cpm/jsg of LDL protein and TCA
precipitability usually exceeded 90%.
As a measure of LDL oxidation, thiobarbituric acid reactive
substance (TBARS) content was determined for all lipoproteins
used according to a published method [6]. One ml of 20% TCA
was added to 100 jil sample of containing 50 to 100 jig of the
lipoprotein. This was followed by the addition of I ml of 1%
thiobarbituric acid and incubation for 45 minutes at 90°C. After
cooling, the samples were centrifuged at 1000 x g at 20°C for 20
minutes and the absorbance of the supernatants was determined
at 532 nm. Data are expressed as malondialdehyde (MDA)
equivalents in nmollmg LDL protein. Tetramethoxypropane
was used as a standard. Our preparations of LDL and labeled
LDL contained no detectable TBARS, whereas the oxidized
LDL contained 20 to 30 nmol MDA equivalent per mg of LDL
protein. Changes in electrophoretic mobility on agarose gels
(0.7% gel, 106 mA, 6 hr) were also used to analyze the LDL
preparations for the degree of oxidation [28, 29].
Binding and uptake of lipoproteins by mesangial cells
Mesangial cells (4th to 10th subculture) were plated onto
24-well cell culture plates (Nunc) at 20,000 cells/mi and grown
in RPM! with 10% fetal calf serum (FCS) to confluence, usually
five days. Media were then changed for 36 hours to lipoprotein
deficient media which consisted of RPM! and 1% FCS, 8% Nu
serum and 1% penicillin/streptomycin. Prior to binding experi-
ments, the cells were kept at 4°C for 20 minutes and the media
removed and replaced by Dulbecco's phosphate buffer solution
with 1 mri Ca, 100 mg% glucose and 2 mg/ml BSA. Labeled
LDL or Ox-LDL (1 p.g/ml) was then added alone or in the
presence of increasing concentrations of unlabeled lipoproteins
or the various additions presented in the results. Equilibrium
binding was achieved by two hours of incubation at 4°C, after
which the media were removed and the cells washed three times
with 2 ml of ice-cold PBS that contained 1% BSA. After a final
wash with PBS, 1 ml of 1 N NaOH was added to each well.
After 24 hours at room temperature the dissolved cells were
collected and each well was washed with 1 ml of PBS with 1%
BSA. Cell associated radioactivity was then measured in a
gamma counter.
Uptake studies of lipoproteins were performed as described
above, except that studies were performed at 37°C and for the
times indicated in Results.
For ['4C1 oleic acid incorporation into cholesteryl oleate,
mesangial cells from the eighth subculture were placed in 9.6
cm2 tissue culture wells at approximately 5 x iO cells/well in
RPMI-1640 supplemented with 10% fetal calf serum and 1%
peniciliinlstreptomycin. After three days media were replaced
with serum deficient media for four hours, and ['4C] oleic acid
(40 jil of the BSA-saline solution, prepared as above) was then
added to the wells, together with either: RPM! with oxidized
LDL (50 or 100 jsg/ml) or RPM! with LDL (50 or 100 jiglml) or
RPM! only. After two hours of incubation at 37°C in 5% CO2
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media were removed and the wells washed twice with PBS.
Cells were removed in PBS by scraping with a rubber police-
man and centrifuged at 4°C at 1000 x g for five minutes.
Aliquots of cells were removed for direct cell count in a
hemocytometer. Supernates were removed and cells were
extracted in 4 ml of chloroform methanol (2:1) for determination
of ['4C] oleate esterfication into cholesterol [30]. The lipid
extracts were resuspended in 200 1 of hexane and spotted on
thin layer silica gel glass plates (Whatman) and developed in
heptane-ethyl ether-acetic acid (85:15:2). Cholesteryl oleate
(Sigma) was run concurrently as a standard. The areas corre-
sponding to the cholesteryl oleate band were scraped and
counted by liquid scintillant chromatography.
Cell proliferation studies
Mesangial cells were plated in 96 well plates at approximately
20,000 cells/mi and maintained for five days until confluent in
RPMI containing 10% fetal calf serum and 1% penicillin!
streptomycin. The media were then changed to lipoprotein
deficient media (as above) for 24 to 36 hours and each well was
washed with PBS. Fresh media containing 1 sCi!ml of [3H]
thymidine and increasing concentrations of LDL or Ox-LDL
were then added, and the cells were incubated for 24 hours. The
cells were then washed with PBS, trypsinized for one hour and
harvested by a PHD cell harvester (Cambridge Technology,
Inc.). Radioactivity associated with the cellular DNA was
measured in a scintillation counter and reflects cell prolifera-
tion. Determinations were performed in triplicate or quadrupli-
cate for each experiment. We also employed the colorimetric
assay of methylene blue incorporation into cells as an additional
method to determine cell number [31]. Cells were grown in 96
well plates as described above, and incubated with varying
amounts of LDL and Ox-LDL for a total of 72 hours. Cell
numbers were determined in triplicate or quadruplicate by
measuring the optical density at 650 nm after incubation with
methylene blue and three washes in a 96-well plate spectropho-
tometer reader (Titertek Multiskan). A standard curve prepared
by serial dilutions of mesangial cells (from 40,000 to 2,000) on 96
well plates allowed conversion of the OD readings to direct cell
numbers.
Prostaglandin determination
Mesangial cells were cultured in 24 well plates and main-
tained for 24 hours in lipoprotein deficient media prior to study.
This medium was then replaced by 2 ml Dulbecco's phosphate
buffer solution with 100 mg% glucose and 2 mg!ml BSA with or
without Ox-LDL or LDL at the concentrations shown in
RESULTS. Aliquots (0.2 ml) of the media Were removed at
times 0, 15, 30, and 60 minutes and measured for PGE2 content
by enzyme immunoassay as described [231.
Gloinerular uptake of lipoproteins in vivo
Male Sprague-Dawley rats (250 to 350 g) were maintained on
tap water and Purina Rat Chow ad libitum. They were fasted for
12 hours prior to being anesthetized via intraperitoneal injection
of pentobarbital. The abdominal aorta was surgically isolated
and radiolabeled LDL or Ox-LDL (specific activity 1 x j6
cpm!p.g) was infused for 10 minutes into the suprarenal abdom-
inal aorta above the origin of the renal arteries. Each animal
received 1.5 x io cpm of lipoprotein per 100 gram body
LDL OX-LDL
Fig. 1. Agarose gel electrophoresis of LDL (left) and oxidized LDL
(right). Fifty micrograms of each lipoprotein was subjected to electro-
phoresis at pH 8.6.
weight. Following a 10-minute equilibration period, the rats
were then sacrificed by exsanguination and the liver, spleen and
kidneys were harvested. Slices of spleen, liver, and kidney
cortex were prepared by a hand held microtome for determina-
tion of the radioactivity. Blood and urine samples were also
taken. Glomeruli and tubular suspensions were isolated from
renal cortex via sequential sieving [26] and the radioactivity was
measured. Samples of each preparation were examined by light
microscopy and consisted of> 90% glomeruli. Protein deter-
minations on the different preparations were done after disso-
lution in 1 N NaOH. All organ radioactivity was reported as
CPM!g of tissue protein.
Statistics
Statistical analysis was performed by Students t-test for
paired analysis or ANOVA with Schefe's correction as indi-
cated. All results are expressed as means + SEM.
Results
Oxidation of LDL
LDL prepared with the inclusion of EDTA in all buffers
showed no evidence of oxidation as assessed by TBARS assay.
Also both unlabeled and [12511 labeled LDL migrated as a single
band by agarose gel electrophoresis (results not shoWn). Incu-
bation of LDL with Cu + in the absence of EDTA resulted in
the formation of 20 to 30 nmol of TBA reactive substances per
mg LDL protein and increased the negative charge as indicated
by increased electrophoretic mobility of the LDL (Fig. 1).
These findings are consistent with the formation of Ox-LDL.
Binding and uptake of LDL and Ox-LDL by mesangial cells
The equilibrium binding of [12511 labeled Ox-LDL or LDL to
mesangial cells was studied by incubating cells with increasing
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Fig. 2. Competition binding curves for [125jj LDL and of['25IJ Ox-LDL
by mesangial cells. Mesangial cells were incubated with 1251 LDL *)
and increasing concentrations of unlabeled Ox-LDL (—0—) and in-
creasing concentrations of unlabeled LDL for 2 hours at 4°C. Analo-
gous experiments were conducted with 1251 Ox-LDL (open small
square). Binding was determined as described in Methods and ex-
pressed per 100 ig cell protein. Results represent means SEM of 5
experiments, each done in duplicate. In addition competition binding of
'i Ox-LDL was performed with 100 pg of unlabeled LDL as depicted
by the large darkened box. Excess LDL (50) only slightly competed for
[12511 Ox-LDL binding. In contrast displacement of 1251 LDL by 100 pg
of unlabeled Ox-LDL was comparable to that by 100 pg/mI of LDL as
depicted by the large open box. The latter results are means SEM of
3 experiments, each done in duplicate.
concentrations of unlabeled Ox-LDL or LDL in the presence of
a constant amount of [125J] labeled lipoprotein (Fig. 2). The
lower displacement curve demonstrates LDL binding to be
saturable with a 75% displacement occurring between 100 and
200 pg/mi of unlabeled LDL addition. Half-maximal displace-
ment for LDL occurred at 5 pg/mi, binding characteristics
consistent with those previously published for MC [231 and for
different cell types [32]. Binding of [125!] Ox-LDL exceeded that
of LDL by four- to fivefold. The displacement curve for
Ox-LDL also shows evidence of saturability at 200 pg/mi of
Ox-LDL, but only 50% displacement of total binding was
observed at this concentration (Fig. 2). This suggests the
existence of specific binding of Ox-LDL with a lower affinity
(half-maximal displacement at 10 to 25 pg/mi) but also a larger
10000 1
Control Poly-1 Heparin
Fig. 3. Effect of heparin and polyinosinic acid on the binding of 125j
LDL (open bar) and 125j Ox-LDL (dark bar) to mesangial cells. Binding
of 1251 labeled LDL or Ox-LDL in the presence or absence of heparin
sulfate (10 mg/mI) or polyinosinic acid (20 pg/mI) was evaluated after 2
hours of incubation at 4°C. Results are mean SEM of 3 sets of
experiments for LDL, and 4 sets for Ox-LDL, each carried out in
duplicate. Asterisks indicate P < 0.05 or better as compared to the
respective controls.
degree of nonspecific binding. The specificity of binding was
examined by competitive displacement of Ox-LDL by LDL and
vice versa. As shown in Figure 2, 100 pg/mI of Ox-LDL was
able to displace LDL binding to about the same extent as an
equal concentration of LDL. In contrast 100 pg/ml of LDL only
displaced Ox-LDL by 15%. These findings indicate that LDL
binds only to the LDL receptor but not to Ox-LDL binding
sites.
We next examined the effects of heparin and polyinosinic
acid on binding of LDL and Ox-LDL to MC. Heparin has been
described to inhibit binding of LDL to its receptor in many cell
types [10, 32] including MC [23, 24]. In addition, heparin and
certain polyanions, such as polyinosinic acid, also block bind-
ing of Ox-LDL to the scavenger receptor [13]. Figure 3 shows
that in fact heparin decreases both LDL and Ox-LDL binding to
MC by 50% to 70%. In contrast polyinosinic acid inhibits
Ox-LDL, but not LDL binding. These findings confirm different
characteristics of the LDL and Ox-LDL binding sites on MC,
which resemble those reported by others for macrophages [33].
The higher degree of Ox-LDL than LDL binding to MC also
translated into increased uptake of Ox-LDL over LDL. As
shown in Figure 4, Ox-LDL uptake by MC at 37°C exceeded
that of LDL by three- to fourfold during the two hours of
incubation.
Uptake of LDL and Ox-LDL by MC was also evaluated by
determining the incorporation of [14C) oleate into intracellular
cholesteryl esters [10, 30, 32]. As shown in Figure 5 at both 50
and 100 .tg/mi Ox-LDL resulted in a three- to fourfold higher
cholesterol esterfication with ['4C] oleate than LDL, consistent
with increased uptake and cellular metabolism of Ox-LDL over
LDL.
Effects of Ox-LDL and LDL on MC proliferation
The effects of increasing concentrations of LDL and Ox-LDL
on mesangial cell proliferation were examined by measuring
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Fig. 4. Time course of binding and internalization of 125j LDL (--El--)
and 125j Ox-LDL f) by mesangial cells at 37°C. Mesangial cells were
incubated at 37°C with 1251 LDL (1 gIml) or '250x-LDL (I j.z.g/ml) for
the indicated times and uptake was evaluated as described in Methods.
Each value represents the mean of 2 experiments, each carried out in
duplicate.
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Fig. 6. Effect of Ox-LDL (4-) or LDL (--EJ--) on [3H] thymidine
incorporation by mesangial cells. Thymidine incorporation into mesan-
gial cells was determined in the presence of increasing concentrations of
LDL or Ox-LDL during 24 hours of culture. Results represent ['HJ
thymidine incorporated per well on 96 well plates and are means SEM
of8 experiments for Ox-LDL and 7 experiments for LDL, each carried
out in triplicate or quadruplicate.
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Fig. 7. Effect of LDL (--EJ--) or Ox-LDL (4-) on mesangial cell number
as measured by the methylene blue uptake assay. Methylene blue
uptake by viable mesangial cells was determined in the presence of
increasing concentrations of LDL or Ox-LDL after a 72 hour incuba-
tion. The results are means SEM of 4 experiments, each carried out in
quadruplicate.
determinations were carried out 72 hours after addition of
Ox-LDL or LDL to allow for changes in cell numbers to take
place. For Ox-LDL, the results further corroborate those seen
with thymidine uptake, demonstrating significantly decreased
cell counts with increased concentration of Ox-LDL (Fig. 7).
Addition of low concentrations of LDL (from 10 to 25 tg/ml)
caused a small increase in the cell number present 72 hours
later, with return to control numbers at 100 p,g/ml of LDL (Fig.
7), results also similar to the thymidine incorporation.
Direct observations under phase contrast microscopy also
confirmed the detrimental effect of Ox-LDL on MC (not shown)
30
20
LDL OxLDL LbL OxLDL
50kg/mI 50kg/mI l00jg/mI 1O0g/mI 0 20 40
(n
'1)C)
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Fig. S. Incorporation of ['4C] oleate into mesangial cell cholesteryl
esters. Mesangial cells were incubated with '4C] oleate plus the
indicated concentrations of LDL or Ox-LDL for 2 hours prior to
extraction of cellular lipids and their analysis as described in Methods.
Values for ['4C] oleate incorporation into cellular cholesteryl esters in
the absence of lipoproteins were subtracted for each experiment.
Results are means SEM of 3 series of experiments at 50 tsg/ml of
lipoproteins and of 2 series at 100 pg/mI and are expressed as pmol
oleate incorporated into cholesteryl esters of 106 cells per hour.
[3H] thymidine incorporation. The addition of Ox-LDL resulted
in a progressive, dose-dependent inhibition of mesangial cell
proliferation, starting with concentrations as low as 25 pg!ml
(Fig. 6). In contrast LDL at 10 to 50 g/ml increased [3H]
thymidine incorporation which returned to baseline at concen-
tration of 250 pg/rnl of LDL. E. coil lipopolysaccharide (from
0.01 to 1 ng/ml) had no effect on MC proliferation (results not
shown), excluding potential endotoxin contamination of LDL
[34] as a reason for the altered thymidine incorporation.
To determine cell proliferation more directly, we used the
methylene blue uptake assay to evaluate MC number. These
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as also reported by others [35, 36]. At 16 to 48 hours after
addition of Ox-LDL from 10 to 100 sgIml, concentration-
dependent changes were noted in the appearance of MC. Cells
retracted and lifted off the culture dish and there was a marked
reduction in normal appearing MC. No morphological changes
were noted in MC incubated in the absence of either Ox-LDL or
LDL. Increasing concentrations of LDL did not produce any
obvious morphological alterations except for an increased gran-
ularity of MC.
Effects of Ox-LDL and LDL on PGE2 production by MC
Lipoproteins can influence prostaglandin synthesis [17, 18,
23, 37], which in turn may influence local microvasculature
physiology [18, 19, 38]. We therefore compared the effects of
Ox-LDL and LDL on synthesis of PGE2, the major prostaglan-
din generated by rat MC [38]. As shown in Figure 8 the addition
of increasing concentrations of LDL showed only a slight
tendency to enhance PGE2 production by MC during a one hour
incubation, and this did not reach significance after the short
incubation period. We have previously shown that LDL can
moderately increase PGE2 production over a 24 hour period
[23]. The addition of Ox-LDL, however, resulted in a rapid and
concentration-dependent increase in PGE2 production by MC.
These findings are similar to those reported for LDL and
Ox-LDL-induced eicosanoid synthesis in other cells [17, 37].
Localization of['251] lipoproteins after in vivo injection
Our in vitro studies demonstrate preferential binding and
uptake of Ox-LDL over LDL by MC. To examine whether
LDL and Ox-LDL would also be taken up in vivo with a similar
preference by glomeruli, we injected [125J] labeled LDL and
Ox-LDL into the suprarenal aorta. Radioactivity was then
determined in isolated glomeruli and tubular suspensions, and
was compared to uptake in spleen and liver. As shown in Figure
9 [125J] LDL was taken up predominantly by liver and spleen,
consistent with published results [39, 40]. Glomerular uptake of
[125J] LDL was greater than that by the tubular tissue, but was
only —20% of that observed in liver when expressed per mg of
tissue protein. Uptake of [1251] Ox-LDL markedly exceeded
that of [125J] LDL in all tissues examined. The increased uptake
of labeled Ox-LDL over LDL was particularly striking in the
glomeruli such that glomerular content of [125J] Ox-LDL per mg
tissue protein reached levels observed in liver. The increase in
uptake of Ox-LDL compared to LDL could not be explained by
different blood levels of the labeled LDL preparations (Fig. 9),
nor did histological examination of the kidney show evidence
for glomerular thrombosis.
Discussion
Recent studies have provided evidence for the existence of
several different types of receptors for modified LDL species,
termed scavenger receptors [13, 14]. These differ from the LDL
receptor in both their binding characteristics [14] and protein
structure [41, 421. Furthermore, the scavenger receptors serve
different functions and are expressed in a restricted number of
cell types [10—14]. While the LDL receptor is present on most
cells, including cultured MC [23, 24], evidence for the presence
of receptors for Ox-LDL had so far been restricted to macro-
phages, hepatic Kupifer cells and possibly endothelial cells
from liver and aorta [10—15]. A physiological function of the
scavenger receptor may be to remove Ox-LDL, thus preventing
deleterious effects of Ox-LDL [5]. Oxidation of LDL has been
proposed as a major factor in the pathogenesis of atherosclero-
sis [5, 43], a hypothesis that may also apply to the glomerular
damage of hyperlipidemia [2]. According to this hypothesis
LDL may undergo oxidation at the site of its accumulation in
the subendothelial space. This may result from either cellular
generation of free radicals or by the transfer of lipid peroxides
into the LDL. Cellular constituents of the vascular wall (endo-
thelial cells, macrophages and smooth muscle cells) are all
capable of oxidizing LDL [5]. Once oxidized, LDL is chemo-
tactic to monocytes and leads to their accumulation while also
inhibiting migration of macrophages from the atherosclerotic
lesion [44]. Furthermore, Ox-LDL is cytotoxic to proliferating
cells [6, 9]. A process similar to the atherosclerotic lesion in the
vessel wall may occur in the mesangium. Because of the
fenestrated glomerular endothelium the mesangium and mesan-
gial cells are constantly exposed to circulating plasma compo-
nents, including LDL. In normolipemic conditions LDL re-
maining in the mesangium will be taken up by LDL receptors of
MC. During hyperlipidemia, however, excessive amounts of
LDL would accumulate in the mesangium and undergo local
oxidation, by either endothelial, mesangial cells [35, 36] or
resident macrophages [45].
In this context, our evidence for binding sites of Ox-LDL on
cultured MC is of interest and is based on a number of
observations. Binding of Ox-LDL markedly exceeds that of
LDL in cultured MC. The binding of Ox-LDL is not competed
for by LDL, but is markedly inhibited by polyinosinic acid, an
agent that does not interfere with LDL binding to MC. In
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Fig. 8. Time course for PGE2 synthesis following
MC incubation with variable concentrations of LDL
(A) or Ox-LDL (B). MC in 24 well culture plates
were incubated with medium only (El, control),
medium plus LDL or medium plus Ox-LDL at the
concentrations given: (--•--) 10 g/ml; (--s--) 20 xg/
ml; (——) 50 gIml. Aliquots of media were taken
at the indicated time points and PGE2 contents were
determined as described in Methods. Results are
means SEM of four series of experiments.
Asterisks indicate P < 0.05 or better as compared to
the respective control values.
Fig. 9. Uptake of LDL compared to Ox-LDL
in normal rats in vivo. 1251 labeled LDL or
Ox-LDL were infused into the aorta above
the renal artery for 10 minutes as described in
Methods. Organs and glomeruli were then
isolated and tissue content of 1251 labeled
LDL or Ox-LDL was determined and
expressed as cpm per microgram of tissue
protein. Results represent the means SEM of
8 animals for LDL and 6 for Ox-LDL.
Asterisks indicate P < 0.05 or better
comparing content of 125! LDL versus 125!
Ox-LDL.
contrast, heparin decreases binding of both LDL and Ox-LDL.
The results of the binding of Ox-LDL and LDL to MC were also
corrorborated by uptake studies. Uptake of Ox-LDL always
exceeded that of LDL using either [125!] labeled lipoproteins or
esterfication of cellular cholesterol with ['4C] oleate as an index
of uptake. All of these characteristics are consistent with those
published for uptake of Ox-LDL on macrophages 1141. It should
be stressed that the cultured MC used in our studies are
essentially free of monocyte-macrophage contamination [46]. It
should be pointed out that our studies were performed with
human LDL on rat mesangial cells, a fact that may influence the
binding characteristics.
The uptake of Ox-LDL by mesangial cells and macrophages
could result in altered cytokine production [47, 48] and ei-
cosanoid synthesis [17, 37]. For example, incubation of macro-
phages with Ox-LDL--—but not LDL— stimulated prostaglandin
and leukotnene synthesis [17]. Similarly, Ox-LDL led to a rapid
stimulation of PGE2 synthesis by MC that exceeds the PGE2
production observed with addition of LDL. The increase in
PGE2 synthesis may in turn influence local hemodynamics and
vascular permeability [18, 38] and alter the biology of resident
macrophages and MC themselves [20, 21]. The potential impor-
tance of enhanced eicosanoid synthesis to hemodynamic
changes in hyperlipidemia is illustrated by our recent studies in
cholesterol-fed rats [19]. In these studies hyperlipidemia re-
sulted in renal vasoconstriction that appeared largely mediated
by increased thromboxane synthesis. The enhanced eicosanoid
production in turn were related to oxidation of LDL, as they
were prevented by probucol treatment [19]. Our present finding
of Ox-LDL induced PGE2 production in MC would be in
agreement with the hypothesis that cellular uptake of Ox-LDL
can be considered as a stimulator of eicosanoid synthesis. The
specific eicosanoid generated would depend on the type of cell
involved. Our results, as well as those reported for endothelial
cells and macrophages, would support this concept [17, 37].
Ox-LDL has been shown to be cytotoxic to a number of cell
types 16, 9] which includes MC, as shown by our present studies
and those by others [35, 36]. In the present study, the evidence
for the cytotoxicity consists of inhibition of [3H] thymidine
incorporation, decrease in actual number of viable MC, and
direct observation demonstrating cell loss. These effects are
observed with as little as 10 p.g/ml of Ox-LDL (Fig. 7). In our
previous studies we had observed inhibition of [3H] thymidine
incorporation at LDL concentrations of 250 jig/mi and greater
[231. As discussed, this was most likely due to oxidation of
some of the LDL during the preparation of LDL or during the
incubation with MC [23, 35, 36]. In any case, local intraglomer-
ular formation of Ox-LDL could contribute to the eventual
glomerular sclerosis by its cytotoxic effect.
We also examined the in vivo uptake of LDL and Ox-LDL by
glomerular cells by determining the amount of label that had
accumulated in glomeruli after intraortic infusion. These exper-
iments showed increased localization of Ox-LDL over LDL to
the glomeruli. The data can not differentiate between uptake of
the lipoproteins by glomerular endothelial, mesangial or epithe-
hal cells, or even mesangial trapping. Clearly, more direct
assignment of the labeled LDL to specific cell types will require
future studies. Furthermore, the increase in glomerular Ox-
LDL could not be attributed to altered renal hemodynamics
that might occur with injection of the tracer amounts of [1251]
Ox-LDL. In two experiments no changes in renal blood flow as
determined by electromagnetic flow probe or in glomerular
filtration by inulin clearance were noted after infusion of tracer
doses of LDL or Ox-LDL. (N. Bank, personal communication.)
The radioactivity in the isolated glomeruli most likely repre-
sents lipoproteins. Glomeruli were isolated 10 minutes after the
infusion of the label, which would be insufficient for extensive
metabolism of the lipoproteins and release of the [1251] label
[14]. This interpretation is also supported by the low level of
radioactivity in the tubular fraction, as it has been shown that
[125!] released from metabolized LDL accumulates in the prox-
imal tubules [39].
In spite of these reservations, it is of interest that Ox-LDL
accumulation in the glomeruli exceeded that of native LDL by
a factor of 10. Thus it reached the same levels as in the liver, the
major site of LDL and Ox-LDL uptake [39], when uptake is
expressed per mg tissue protein. Irrespective of the glomerular
cell type responsible for this marked uptake of Ox-LDL, these
results indicate a high density of Ox-LDL receptors in glomer-
uli. Based on our in vitro results with cultured MC, we would
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propose that mesangial cells could certainly be one cell type
contributing to the high glomerular uptake of Ox-LDL. It
should be pointed out that our in vivo injection studies of
Ox-LDL only partially mimic a physiological condition. In vivo
Ox-LDL would be formed and disposed of locally and would
unlikely be found in the circulation [5]. Nonetheless, we believe
that our results reflect the binding capacity of the glomerulus for
Ox-LDL. Certainly the marked differences between the glomer-
ular accumulation of LDL and Ox-LDL cannot be explained by
altered hemodynamics, as the tracer infusion did not alter renal
blood flow. Furthermore, trapping of plasma in the isolated
glomeruli cannot account for the observed differences, as
plasma levels of [12511 LDL and [1251] Ox-LDL were identical.
Changes in the charge of Ox-LDL as compared to LDL can also
not explain the differences. Ox-LDL is more anionic (Fig. 1),
which should decrease its interaction with negatively charged
surfaces of glomerular cells.
In the in vivo studies, small differences could arise in the
specific activity of LDL versus Ox-LDL achieved in the circu-
lation. The specific activity of the injected [1251] LDL (1 x 106
CPM4g) will be diluted by the rat's own circulating LDL which
ranges from 200 to 400 p.gIml. This will not be the case for the
injected [125j] Ox-LDL as there is little or no circulating
Ox-LDL. It is unlikely, however, that such differences in
specific activities could fully account for the tenfold higher
glomerular uptake of labeled Ox-LDL versus LDL, as the
increase in the liver was only fivefold. If the increased uptake of
the tracer Ox-LDL were simply due to different specific activ-
ities, it should increase to the same degree in all tissues
examined. Furthermore, issues of specific activity do not apply
to our in vitro studies. Finally, the specific activity may be
difficult to evaluate as LDL is a minor lipid fraction in normal
rats and as we used human LDL in the rat studies.
In conclusion, we propose that our studies provide further
evidence in support of the analogy between the pathogenesis of
atherosclerosis and glomeruloscierosis as a complication of
hyperlipidemia in renal diseases. Due to the fenestrated endo-
thelium of the glomerulus, lipoproteins may have relatively
easy access to the mesangium. LDL may then be trapped in the
mesangial matrix, where it would be exposed to reactive
oxygen species, whose production is increased in various
experimental glomerular diseases [49]. Oxidation of LDL would
then follow, leading to its cytotoxicity and internalization by
mesangial cells and macrophages. The resulting release of
various mediators, including eicosanoids, could further influ-
ence mesangial and endothelial cell biology, matrix deposition,
and hemodynamics. Furthermore Ox-LDL, via its chemotactic
properties, can attract more macrophages and inhibit their
egress from the glomerulus. This theory is derived from that
postulated for the progression of the atherosclerotic lesion and
needs to be tested further.
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